These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Activation of NFAT signaling in podocytes causes glomerulosclerosis. Wang Y, Jarad G, Tripathi P, Pan M, Cunningham J, Martin DR, Liapis H, Miner JH, Chen F. J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158 [Abstract] [Full Text] [Related]
9. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease. Kistler AD, Singh G, Altintas MM, Yu H, Fernandez IC, Gu C, Wilson C, Srivastava SK, Dietrich A, Walz K, Kerjaschki D, Ruiz P, Dryer S, Sever S, Dinda AK, Faul C, Reiser J. J Biol Chem; 2013 Dec 20; 288(51):36598-609. PubMed ID: 24194522 [Abstract] [Full Text] [Related]
12. Gq signaling causes glomerular injury by activating TRPC6. Wang L, Jirka G, Rosenberg PB, Buckley AF, Gomez JA, Fields TA, Winn MP, Spurney RF. J Clin Invest; 2015 May 20; 125(5):1913-26. PubMed ID: 25844902 [Abstract] [Full Text] [Related]
13. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli. Ilatovskaya DV, Palygin O, Chubinskiy-Nadezhdin V, Negulyaev YA, Ma R, Birnbaumer L, Staruschenko A. Kidney Int; 2014 Sep 20; 86(3):506-14. PubMed ID: 24646854 [Abstract] [Full Text] [Related]
15. Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia. Yu Y, Zhang L, Xu G, Wu Z, Li Q, Gu Y, Niu J. Kidney Blood Press Res; 2018 Sep 20; 43(5):1666-1676. PubMed ID: 30380548 [Abstract] [Full Text] [Related]
16. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Ilatovskaya DV, Staruschenko A. Am J Physiol Renal Physiol; 2015 Sep 01; 309(5):F393-7. PubMed ID: 26084930 [Abstract] [Full Text] [Related]
17. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1. Huang H, You Y, Lin X, Tang C, Gu X, Huang M, Qin Y, Tan J, Huang F. Cell Physiol Biochem; 2017 Sep 01; 41(1):163-172. PubMed ID: 28214865 [Abstract] [Full Text] [Related]
18. TRPC6 enhances angiotensin II-induced albuminuria. Eckel J, Lavin PJ, Finch EA, Mukerji N, Burch J, Gbadegesin R, Wu G, Bowling B, Byrd A, Hall G, Sparks M, Zhang ZS, Homstad A, Barisoni L, Birbaumer L, Rosenberg P, Winn MP. J Am Soc Nephrol; 2011 Mar 01; 22(3):526-35. PubMed ID: 21258036 [Abstract] [Full Text] [Related]
19. β-Arrestin pathway activation by selective ATR1 agonism promotes calcium influx in podocytes, leading to glomerular damage. Semenikhina M, Fedoriuk M, Stefanenko M, Klemens CA, Cherezova A, Marshall B, Hall G, Levchenko V, Solanki AK, Lipschutz JH, Ilatovskaya DV, Staruschenko A, Palygin O. Clin Sci (Lond); 2023 Dec 22; 137(24):1789-1804. PubMed ID: 38051199 [Abstract] [Full Text] [Related]
20. Insulin Increases Expression of TRPC6 Channels in Podocytes by a Calcineurin-Dependent Pathway. Xia S, Liu Y, Li X, Thilo F, Tepel M. Cell Physiol Biochem; 2016 Dec 22; 38(2):659-69. PubMed ID: 26849622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]